Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction

PHASE2CompletedINTERVENTIONAL
Enrollment

1,257

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Coronary Atherosclerosis
Interventions
DRUG

Hexadecasaccharide (SR123781A)

Trial Locations (18)

1642

Sanofi-Aventis, Buenos Aires

103045

Sanofi-Aventis, Moscow

Unknown

Sanofi-Aventis, Bridgewater

Sanofi-Aventis, Providencia

Sanofi-Aventis France, Paris

Sanofi-Aventis, India

Sanofi-Aventis, Seoul

NSW 2113

Sanofi-Aventis, Macquarie Park

18 31

Sanofi-Aventis, Diegem

05677-000

Sanofi-Aventis, São Paulo

H7L 4A8

Sanofi-Aventis, Laval

160 00

Sanofi-Aventis, Prague

04000

Sanofi-Aventis, México

2803 PE

Sanofi-Aventis, Gouda

02-672

Sanofi-Aventis, Warsaw

2740-244

Sanofi-Aventis, Porto Salvo

08019

Sanofi-aventis, Barcelona

34 394

Sanofi-Aventis, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY